By Laura Frost, Michael R. Reich, Tadataka Yamada, Beth Anne Pratt, Alan Fenwick, Howard Thompson
many of us in constructing international locations lack entry to future health applied sciences, even easy ones. Why do those difficulties in entry persist? What should be performed to enhance entry to reliable health and wellbeing applied sciences, specially for negative humans in bad international locations?
This e-book solutions these questions by way of constructing a finished analytical framework for entry and analyzing six case reports to give an explanation for why a few wellbeing and fitness applied sciences accomplished extra entry than others. The applied sciences comprise praziquantel (for the therapy of schistosomiasis), hepatitis B vaccine, malaria swift diagnostic assessments, vaccine vial displays for temperature publicity, the Norplant implant contraceptive, and feminine condoms. according to study experiences commissioned by means of the invoice & Melinda Gates starting place to raised comprehend the improvement, adoption, and uptake of well-being applied sciences in negative international locations, the booklet concludes with particular classes on innovations to enhance entry. those classes can be of willing curiosity to scholars of wellbeing and fitness and improvement, public health and wellbeing pros, and wellbeing and fitness know-how developers—all who search to enhance entry to healthiness applied sciences in negative international locations.
Read or Download Access: How Do Good Health Technologies Get to Poor People in Poor Countries? (Harvard Series on Population and International Health) PDF
Best epidemiology books
Detailing the clinical ideas underlying the success of sterility, this detailed reference examines either a large spectrum of useful, common sterilization approaches and the equipment on hand to verify sterility-assessing the strengths and barriers of every expertise. Delineates present regulatory specifications for sterility-emphasizing the significance of aseptic methods within the scientific institution and the pharmaceutical undefined!
''Provides present types, instruments, and examples for the formula and overview of clinical hypotheses in causal phrases. Introduces a brand new approach to version parametritization. Illustrates structural equations and graphical components for complicated causal platforms. ''
This worthwhile textual content provides tools and methods for carrying out an animal disorder surveillance software, and constructing an animal overall healthiness moitoring process. The textual content is a 'recipe publication' for those options because it explains glossy strategies, whereas emphasizing the basics and rules of utilizing those innovations.
- Computer-aided Technologies: Applications in Engineering and Medicine
- Land Law Reform: Achieving Development Policy Objectives (Law, Justice, and Development)
- Epidemic: The Past, Present and Future of the Diseases that Made Us
- Applied Regression Modeling, Second Edition
Extra resources for Access: How Do Good Health Technologies Get to Poor People in Poor Countries? (Harvard Series on Population and International Health)
Due to efforts by activist organizations, producers, UN agencies, and groups such as the William J. 27 While pricing controversies for most health technologies are usually less dramatic than has been the case for ARVs, global and national organizations are using a variety of strategies to influence health technology prices in developing countries. Many of the case studies in this volume examine what has worked and what has not in reducing prices. 28 | C H A P T E R 2 | T H E A C C E S S F R A M E W O R K Activity Stream 4: Adoption Adoption involves gaining acceptance and creating demand for a new health technology from actors at several levels: global organizations, government actors in developing countries, providers and dispensers, and individual consumers and patients.
Our framework has several limitations worth noting. First, it is not a “one size fits all” approach. The access story for each health technology differs by product and context. A second limitation is that the framework is not the only way to organize or think about access to health technologies. For some, this framework may be too complicated to be useful; for others, it may not include enough detail about the different activities or actors. We have tried to find a balance between detail and simplicity and to identify categories that speak to practical action but also draw upon theoretical concepts.
39 Marc J. Roberts, William Hsiao, Peter Berman, and Michael R. Reich, Getting Health Reform Right: A Guide to Improving Performance and Equity (New York: Oxford University Press, 2004): 281–307. 38 | C H A P T E R 2 | T H E A C C E S S F R A M E W O R K 40 Everett M. Rogers, Diffusion of Innovations (New York: Free Press of Glencoe, 1962). 41 Zvi Griliches, “Hybrid Corn: An Exploration in the Economics of Technological Change,” Econometrics 25 (1957): 501–522. 42 Vinay R. ’ Cultural Knowledge and the Micropolitics of Therapy Seeking for Childhood Febrile Illness in Tanzania,” Social Science & Medicine 62 (2006): 2945–2959.
Access: How Do Good Health Technologies Get to Poor People in Poor Countries? (Harvard Series on Population and International Health) by Laura Frost, Michael R. Reich, Tadataka Yamada, Beth Anne Pratt, Alan Fenwick, Howard Thompson